Product NDC: | 0069-9321 |
Proprietary Name: | Fludarabine Phosphate |
Non Proprietary Name: | Fludarabine Phosphate |
Active Ingredient(s): | 25 mg/mL & nbsp; Fludarabine Phosphate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-9321 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200647 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111222 |
Package NDC: | 0069-9321-22 |
Package Description: | 2 mL in 1 VIAL (0069-9321-22) |
NDC Code | 0069-9321-22 |
Proprietary Name | Fludarabine Phosphate |
Package Description | 2 mL in 1 VIAL (0069-9321-22) |
Product NDC | 0069-9321 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludarabine Phosphate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111222 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
Substance Name | FLUDARABINE PHOSPHATE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |